MILORevenue Intelligence
Portfolio demonstration — synthetic data at an expanded scale, modeling a system originally built for a real client. Nothing shown here is real client data.Read the full note →
← All opportunities

Solvane Care Group NV

Healthcare / Care Staffing · Belgium · 180 employees · Owned by Rasmus Holm

64.6
Moderate

MILO’s Recommendation

Personalized Outreach

Despite shallow engagement (score: 38), the account demonstrates exceptional timing (78) driven by a vendor EOL notice issued ~60 days ago, placing Solvane in an immediate 3-6 month replacement window. The strong fit (72) — mid-market healthcare staffing, 13.6% growth, 180 employees — aligns with Atlas's ICP. While only one HR manager contact exists and no decision-makers are mapped, the webinar attendance on 2025-11-01 signals active problem awareness and receptiveness. The convergence of acute pain (legacy EOL), favorable timing, and demonstrated interest creates a narrow window that requires immediate action. Waiting to research further risks losing the account to competitors already engaged in their evaluation. The priority is personalized outreach to Liesel Karlsson to validate her interest, understand their replacement timeline, and rapidly multi-thread to IT/Operations decision-makers before the procurement window closes. The moderate overall score (64.6) is suppressed primarily by engagement depth, which outreach will directly address, rather than by fundamental disqualifying factors.

medium confidence

Draft EmailEmail·Liesel Karlsson, HR Operations Manager

Re-engage Solvane Care Group NV with a message grounded in the specific signal(s) that raised its priority.

Draft Message

Subject: Solvane Care Group NV — vendor event

Hi Liesel, I saw that Solvane Care Group NV current scheduling vendor issues an end-of-life notice for their legacy product — that's exactly the kind of moment where a workforce-management review tends to pay off. Solvane Care Group NV is a 180-employee healthcare/care staffing organization based in Belgium. Would it be useful to spend 20 minutes walking through how teams like HR Operations Managers at similar healthcare / care staffing companies are using Atlas, and whether it's relevant to what you're dealing with right now? Best, [Account Owner]

View MILO Brief →

Score Breakdown

Fit (20%)
72
Intent (20%)
65
Timing (15%)
78
Value (15%)
58
Engagement (10%)
38
Strategic Relevance (10%)
68
Evidence Quality (10%)
62

Weighted formula: opportunity-score-v1. Populated from structured evidence — see the MILO Analysis below for what grounds each dimension.

MILO Analysis

Solvane Care Group NV is a 180-employee Belgian healthcare staffing organization currently running legacy end-of-life software. A vendor EOL notice issued ~60 days ago creates an immediate replacement window. One HR manager contact showed early interest via webinar attendance. The account demonstrates strong fit (growth trajectory, industry alignment, acute pain) and favorable timing, but engagement is shallow and requires rapid multi-threading to decision-makers before the evaluation window narrows.

  • fact

    Solvane Care Group NV is a 180-employee healthcare/care staffing organization based in Belgium.

    account:nameaccount:countryaccount:industryaccount:employeeCount

  • fact

    The account is growing at 13.6% year-over-year.

    account:growthRatePct

  • fact

    Solvane currently uses a legacy vendor solution that is at end-of-life.

    account:existingSoftware110354b4-f205-4934-b209-cfaa2c039400

  • fact

    On 2026-01-01, the current scheduling vendor issued an end-of-life notice for their legacy product.

    110354b4-f205-4934-b209-cfaa2c039400

  • inference

    Approximately 60 days have elapsed since the vendor EOL signal, placing the account in the expected 3–6 month procurement decision window.

    110354b4-f205-4934-b209-cfaa2c039400account:referenceDate

  • fact

    Liesel Karlsson is an HR Operations Manager at Solvane and is not identified as a decision-maker.

    926983d9-7025-427d-a286-f08449a28148

  • fact

    Liesel attended an Atlas webinar on 2025-11-01 under a personal email address; she was loosely matched by name to this contact record.

    2ead5ee2-76a3-4980-ade7-c1b45005abc1

  • inference

    The webinar attendance suggests early-stage problem awareness and receptiveness to workforce-management solutions.

    2ead5ee2-76a3-4980-ade7-c1b45005abc1

  • fact

    No decision-makers have been identified or engaged to date; only one manager-level contact in HR is currently mapped.

    926983d9-7025-427d-a286-f08449a28148

  • fact

    No formal sales opportunity has been created for this account.

    account:opportunities

  • inference

    The account profile (mid-market healthcare staffing, high growth, acute replacement need) aligns with Atlas's ideal customer profile.

    account:industryaccount:employeeCountaccount:growthRatePctaccount:existingSoftware

  • fact

    Estimated deal value is unknown; no seat count, revenue, or pricing data is available in the CRM.

    account:annualRevenueEuraccount:seatCount

  • assumption

    Given the account size and industry, a typical deal value in the range of €80k–€150k ACV is plausible, but this is an assumption pending discovery.

    account:employeeCountaccount:industry

Caveats

  • — Webinar attendee was loosely matched by name under a personal email; contact identity requires validation.
  • — No decision-maker or executive engagement has occurred; stakeholder map is incomplete.
  • — No revenue, seat count, or pricing guidance is available; deal sizing is speculative.
  • — No evidence of active competitor evaluation or defined timeline; urgency is inferred from the EOL signal.
  • — Single-threaded engagement through one non-decision-maker contact; multi-threading is critical.

Value Impact

Estimated deal value€37,620
AssumptionValueSourceConfidence
assumed per employee value€380/employee/yearassumption40%
base deal value€68,400estimate40%
probability weighting55%calculated30%
probability weighted value€37,620calculated30%

Account Snapshot

Annual revenue
—
Growth rate
13.6%
Funding status
—
Existing software
Legacy vendor (end-of-life)